Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novogen Ltd (NASDAQ:NVGN)

1.84
Delayed Data
As of Jul 22
 -0.01 / -0.54%
Today’s Change
1.79
Today|||52-Week Range
4.07
-11.96%
Year-to-Date
No recent news for Novogen Ltd.

Today’s Trading

Previous close1.85
Today’s open1.85
Day’s range1.83 - 1.90
Volume26,659
Average volume (3 months)32,818
Market cap$31.8M
Dividend yield--
Data as of 3:59pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)+42.50%
Earnings growth (this year)-4.75%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book0.95

Competitors

 Today’s
change
Today’s
% change
PULMPulmatrix Inc-0.02-0.92%
HEBHemispherx Biopharma...-0.00-2.70%
SBOTStellar Biotechnolog...-0.00-0.00%
PPHMPPeregrine Pharmaceut...-0.10-0.47%
Data as of 3:59pm ET, 07/22/2016

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$5.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
James Garner
Chief Financial Officer
Cristyn Humphreys
Corporate headquarters
Hornsby, New South Wales (nsw)

Forecasts

Partner Offers

Search for Jobs